EARLI
Mark Identification

EARLI

Serial Number

88020634

Filing Date

Jun 29, 2018

Registration Date

Mar 14, 2023

Trademark by

EARLI INC.

Active Trademark

Classification Information

Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use

Chemicals

Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases

Pharmaceuticals